Projected Earnings Date: 2024-08-16    (Delayed quote data   2025-06-30)
Last
 2.52
Change
 ⇑ +0.02   (+0.80%)
Volume
  63,522
Open
 2.55
High
 2.57
Low
 2.48
8EMA (Daily)
 2.81
40EMA (Daily)
 4.26
50EMA (Daily)
 4.39
STO (Daily)
 13.217
MACD Hist (Daily)
 -0.024
8EMA (Weekly)
 3.760
40EMA (Weekly)
 6.86
50EMA (Weekly)
 21.36
STO (Weekly)
 13.007
MACD Hist (Weekly)
 -0.165
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com